Archive: 03/06/2015
Past failures pave way for promising new Alzheimer's treatments
Since 2002, close to 300 drug candidates to treat Alzheimer's have run into clinical dead ends. But now, having learned from those failures, researchers are testing—and retesting—a batch of the most promising compounds ...
Jun 3, 2015
Study supports IDH gene as prognostic marker in anaplastic astrocytoma
New findings suggest that a gene called IDH1 might be prognostic marker for a rare form of brain cancer. Patients in this study who had a mutated IDH gene lived an average of 7.9 years after diagnosis versus 2.8 years for ...
Jun 3, 2015